Newsmeme!
Discover News you didn't know existed
Biological Therapy
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Novartis highlights innovative approach to drug discovery with dynamic advance in exploratory pipeline
Published November 20, 2008, 7:49 pm, PharmaBiz
Novartis highlighted at an investor event on November 19, the success of its pharmaceuticals research strategy in delivering novel compounds to the clinic, reflecting the benefits of sustained investments in Research and Development.
Iressa Proves Just as Effective as Chemotherapy for Lung Cancer
Published November 20, 2008, 4:25 pm, Newswise
Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial, led by researchers at The University of Texas M. D. Anderson Cancer Center.
Maggot Therapy May Soon Be Covered By Your Insurance
Published November 20, 2008, 4:01 pm, FOX 61 Chattanooga
In the 2000 film 'Gladiator,' the main character Maximus, played by Russell Crowe, is cut and bruised. He had some wounds that were looking pretty nasty. One of the other enslaved fighter treats his shoulder by placing maggots in the wound.
Randomized Phase 2 Study Of IMC-A12 For HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
Published November 20, 2008, 12:09 pm, Medical News Today
ImClone Systems Incorporated (NASDAQ: IMCL), a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that its disease-directed randomized Phase 2 clinical trial of IMC-A12 in patients with previously treated HER2-expressing locally advanced or metastatic breast cancer has commenced patient enrollment.
EDITORIAL COMMENT | Tailoring Transplants
Published November 20, 2008, 11:10 am, The Times of India
Stem cell research and therapy is progressing so rapidly across the globe now that it holds hope for countless future patients with a wide variety of ailments.
Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for ...
Published November 20, 2008, 10:33 am, PR Newswire via Yahoo! Finance
Bionovo, Inc. announced the company will present results from the Phase 1B clinical trial of their lead drug candidate for advanced metastatic breast cancer, BZL101, at the Society for Integrative Oncology's Fifth International Conference in Atlanta, Georgia.
Invitrogen Launches In Vivo RNAi Delivery Reagent - Products To Simplify And Enable Research On All Sequencing Platforms
Published November 20, 2008, 9:08 am, Medical News Today
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the introduction of its Invivofectamine™ delivery reagent which enables short interference ribonucleic acid (siRNA) experiments in vivo.
GE to develop biotic man
Published November 20, 2008, 7:46 am, Connecticut Post
NISKAYUNA, N.Y. - GE Global Research, the technology development arm for the General Electric Co., announced today a two-year, $1.1 million collaboration with the Transformational Medical
GE To Develop Biotic Man To Help Accelerate Drug Development
Published November 20, 2008, 6:11 am, Business Wire via Yahoo! Finance
NISKAYUNA, N.Y.----GE Global Research, the technology development arm for the General Electric Company , announced today a two-year, $1.1 million collaboration with the Transformational Medical Technologies Initiative to develop a physiologically based "virtual human.” This collaboration is supported by a contract awarded by the Defense Threat Reduction Agency , a division of the U.S.
Invitrogen and Applied Biosystems Announce Preliminary Results of Election Regarding Merger Consideration
Published November 20, 2008, 5:30 am, Business Wire via Yahoo! Finance
CARLSBAD, Calif. & NORWALK, Conn.----Invitrogen Corporation and Applied Biosystems Inc. today announced the preliminary results of elections made by Applied Biosystems stockholders regarding their preferences as to the form of merger consideration they will receive in the pending acquisition of Applied Biosystems by Invitrogen.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |